Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

BTMD stock hub

biote Corp. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BTMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

81.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

BTMD

In the news

Latest news · BTMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.1

P25 12.3P50 18.4P75 33.1

Trailing P/E5.1

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC49.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BTMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001819253
Company name	biote Corp.
Country	United States
Country code	US
Cusip	090683103
Employees	223
Employees Change	6%
Employees Change Percent	2.76
Enterprise value	$184.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Care Facilities
Isin	US0906831039
Last refreshed	2026-05-10
Market cap	$81.2M
Market cap category	Micro-Cap
Price	$2.18
Price currency	USD
Rev Per Employee	843,775.78x
Sector	Healthcare
Sic	2833
Symbol	BTMD
Website	https://www.biote.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	19.21%
EV Earnings	11.81x
EV/EBIT	6.46x
EV/EBITDA	5.92x
EV/FCF	6.38x
EV/Sales	0.98x
FCF yield	35.55%
Forward P/E	10.14x
P/E ratio	5.08x
P/S ratio	0.43x
PE Ratio3 Y	24.26x
PE Ratio5 Y	19.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.17%
EBITDA Margin	16.55%
FCF margin	15.35%
Gross margin	70.12%
Gross Profit	$131.9M
Gross Profit Growth	-7.15%
Gross Profit Growth Q	-14.92%
Gross Profit Growth3 Y	4.24%
Gross Profit Growth5 Y	14.72%
Net Income	$15.6M
Net Income Growth	-25.82%
Net Income Growth Q	-83.4%
Net Income Growth Years	1%
Net Income Growth5 Y	-6.02%
Pretax Margin	12.47%
Profit Margin	8.29%
Profit Per Employee	$69,973
Profitable Years	3
ROA	16.8
Roa5y	15.41
ROCE	46.94
ROIC	49.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-34.75%
Cagr3y	-30.19%
Cagr5y	-26.27%
EPS Growth	-28.53
EPS Growth Q	-83.78
EPS Growth Years	1
EPS Growth5 Y	-54.39
FCF Growth	-21.9%
FCF Growth Q	-26.81%
FCF Growth5 Y	3.22%
OCF Growth	-26.41%
OCF Growth Q	-39.66%
OCF Growth5 Y	5.17%
Revenue Growth	-5.63x
Revenue Growth Q	-8.28x
Revenue Growth Years	0x
Revenue Growth3 Y	2.91x
Revenue Growth5 Y	11.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.77
Assets	$89M
Cash	$5.3M
Current Assets	$36.4M
Current Liabilities	$28.2M
Debt	$108.4M
Debt EBITDA	$3.4
Debt FCF	$3.75
Equity	$-48M
Interest Coverage	2.85
Liabilities	$137M
Long Term Assets	$52.7M
Long Term Liabilities	$108.8M
Net Cash	$-103.1M
Net Cash By Market Cap	$-127
Net Debt EBITDA	$3.31
Net Debt FCF	$3.57
Tangible Book Value	$-71M
Tangible Book Value Per Share	$-2.32
WACC	10

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.29
Inventory Turnover	3.14
Net Working Capital	$9.7M
Quick ratio	0.45
Working Capital	$8.1M
Working Capital Turnover	$13.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.52%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-34.73%
200-day SMA	2.57
3Y total return	-65.99%
50-day SMA	1.83
50-day SMA vs 200-day SMA	50under200
5Y total return	-78.2%
All Time High	10.53
All Time High Change	-79.29%
All Time High Date	2022-05-24
All Time Low	1.27
All Time Low Change	71.65%
All Time Low Date	2026-03-27
ATR	0.14
Beta	1.71
Beta1y	2.47
Beta2y	1.54
Ch YTD	-16.15
High	2.24
High52	4.75
High52 Date	2025-07-29
High52ch	-54.11%
Low	2.01
Low52	1.27
Low52 Date	2026-03-30
Low52ch	71.65%
Ma50ch	19.45%
Premarket Change Percent	-3.67
Premarket Price	$2.01
Premarket Volume	101
Price vs 200-day SMA	-15.21%
RSI	58.77
RSI Monthly	37.38
RSI Weekly	47.39
Sharpe ratio	-0.38x
Sortino ratio	-0.42
Total Return	-4.52%
Tr YTD	-16.15
Tr1m	46.31%
Tr1w	-0.46%
Tr3m	-2.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$2
Analyst Ratings	Strong Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$0.08
Earnings EPS Estimate Growth	-78.38
Earnings Revenue Estimate	46,055,600x
Earnings Revenue Estimate Growth	-5.99x
Operating Income	$28.5M
Operating Income Growth	-22.74
Operating Income Growth Q	-67.33
Operating Income Growth5 Y	3.94
Operating margin	15.17
Price target	$2.83
Price Target Change	$29.82
Price Target Change Top	$-8.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,136,823%
Float Percent	56.72%
Net Borrowing	-57,331,000
Shares Insiders	12.63%
Shares Institutions	43.13%
Shares Out	37,268,005
Shares Qo Q	16.77%
Shares Yo Y	4.52%
Short Float	7.98%
Short Ratio	4.81
Short Shares	4.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$20.3M
Average Volume	199,889.2x
Bv Per Share	-1.83
CAPEX	$-3.7M
Ch1m	46.31
Ch1w	-0.46
Ch1y	-34.73
Ch3m	-2.24
Ch3y	-65.99
Ch5y	-78.2
Ch6m	-19.56
Change	4.31%
Change From Open	4.81
Close	2.09
Days Gap	-0.48
Depreciation Amortization	2,593,000
Dollar Volume	424,932.1
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$28.5M
EBITDA	$31.1M
EPS	$0.43
F Score	6
FCF	$28.9M
FCF EV Yield	15.67x
FCF Per Share	$0.77
Financing CF	-62,837,000
Fiscal Year End	December
Founded	2,012
Goodwill	5,833,000
Income Tax	$5M
Investing CF	-6,184,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-13
Lynch Fair Value	$2.14
Lynch Upside	-1.65
Ma150	2.3
Ma150ch	-5.34%
Ma20	2.15
Ma20ch	1.21%
Net CF	-36,380,000
Next Earnings Date	2026-08-05
Open	2.08
Optionable	No
P FCF Ratio	2.81
P OCF Ratio	2.49
Position In Range	73.78
Post Close	2.18
Postmarket Change Percent	-6.57
Postmarket Price	$2.04
Ppne	13,259,000
Pre Close	2.09
Price Date	2026-05-08
Price EBITDA	$2.61
Relative Volume	0.98x
Revenue	188,162,000x
SBC By Revenue	4.55x
Share Based Comp	8,552,000
Tax By Revenue	2.67x
Tax Rate	21.45%
Tr6m	-19.56%
Us State	Texas
Volume	194,923
Z Score	2.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BTMD pay a dividend?

Capital-return profile for this ticker.

Performance

BTMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BTMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+43.1%

Float: +56.7% of shares outstanding

Insider ownership

+12.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BTMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.8

Neutral momentum band

Price vs 200-day MA

-15.2%

50/200-day relationship not available

Beta (5Y)

1.71

More volatile than the market

Sharpe ratio

-0.38

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BTMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current BTMD stock rating?

biote Corp. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full BTMD analysis?

The full report lives at /stocks/BTMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for BTMD?

The latest report frames BTMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the BTMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.